Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines



Rating:

Share or cite this content

Citations should be made in the following way:
T. Ferkol (St. Louis, United States of America). Case study in cystic fibrosis: the US CF Foundation research and clinical development programmes. Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines

Member's Comments

No comment yet.

Related content which might interest you: The German cystic fibrosis quality assurance project: clinical features in children and adults Source: Eur Respir J 2001; 17: 1187-1194 Year: 2001 Patient centred research: a model for involving cystic fibrosis (CF) patients in research planning Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019 Public awareness on cystic fibrosis: results from a national pragmatic survey Source: Eur Respir J 2015; 46: 264-267 Year: 2015 Cystic fibrosis registry: A preliminary report of CF patient from NRITLD Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012 Assessment of NuvoAir platform use on clinical outcomes in adults with cystic fibrosis: a first Italian experience Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021 Medical rehabilitation programme in cystic fibrosis Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment Year: 2009 Clinical, functional and microbiological characteristics of an adult brazilian cystic fibrosis population Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 National survey of hearing assessment in patients with cystic fibrosis in the UK Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Research priorities in bronchiectasis: A consensus from the European multicentre bronchiectasis audit and research collaboration (EMBARC) study group Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Newborn screening for cystic fibrosis - lessons from national programmes in Europe Source: International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children Year: 2018 Audit of management of pseudomonas aeruginosa infection in children with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Physiotherapy adherence and perception in patients with cystic fibrosis: A descriptive study Source: International Congress 2015 – Physiotherapy assessment and techniques in pulmonary and non-pulmonary conditions Year: 2015 The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Implementation of non-medical prescribing within the clinical cystic fibrosis setting Source: International Congress 2014 – Physiotherapy and physical activity in respiratory conditions Year: 2014 Use of national disease registries in the conduct of long-term post-authorisation drug safety studies (LTSSs) Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Newborn screening for cystic fibrosis: opportunities and remaining challenges Source: Eur Respir Monogr 2014; 64: 65-76 Year: 2014 From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006 Source: Eur Respir J 2008; 31: 29-35 Year: 2008